Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,155 | -11,103 | -10,338 | -9,585 | -11,950 |
| Depreciation Amortization | 431 | 352 | 273 | 157 | 400 |
| Accounts receivable | N/A | N/A | N/A | N/A | -86 |
| Other Working Capital | 4,382 | 4,898 | 5,618 | 8,262 | -1,670 |
| Other Operating Activity | 326 | 242 | 142 | 59 | -684 |
| Operating Cash Flow | $-6,016 | $-5,611 | $-4,305 | $-1,107 | $-13,990 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,496 | 12,038 | 4,840 | 17 | -35,030 |
| PPE Investments | -57 | -57 | -43 | -16 | -310 |
| Other Investing Activity | -157 | -195 | -146 | -69 | 1,730 |
| Investing Cash Flow | $4,282 | $11,786 | $4,651 | $-68 | $-33,610 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 139 | 116 | 113 | 99 | 75 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -5 |
| Financing Cash Flow | $139 | $116 | $113 | $99 | $70 |
| Beginning Cash Position | 4,106 | 4,106 | 4,106 | 4,106 | 51,640 |
| End Cash Position | 2,511 | 10,397 | 4,565 | 3,030 | 4,100 |
| Net Cash Flow | $-1,595 | $6,291 | $459 | $-1,076 | $-47,530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,016 | -5,611 | -4,305 | -1,107 | -13,990 |
| Capital Expenditure | -57 | -57 | -43 | -16 | -311 |
| Free Cash Flow | -6,073 | -5,668 | -4,348 | -1,123 | -14,301 |